Care

The combination will allow healthcare and life sciences companies to respond more efficiently to research questions.  

The company will use the funds to scale its technologies and expand its services.  

Blackrock Neurotech will offer Cognixion's noninvasive Axon-R wearable device through its distribution network.  

The company offers an at-home test where a breath sample is collected and analyzed by trained dogs and AI to detect early-stage cancer.

The offering measures AI's real-world performance and safety around handling realistic medical conversations, using physician-created rubrics and GPT-4.1 scoring.

Lunit and Coreline Soft have been tapped to join large-scale cancer screening programs.

Emotional regulation could be the missing piece of the chronic pain treatment puzzle, says Australian researchers. 

Anu Sharma, founder and CEO of Millie, discusses President Trump's proposal of providing a baby bonus to incentivize people to have children.

Users implanted with Synchron’s BCI will be able to control iPhone, iPad and Apple Vision Pro with their thoughts without physical movement or voice commands.  

Aimee Corso, senior vice president of growth at Mirvie, discusses the women's health company's direct-to-consumer test to help pregnant women predict preeclampsia before its onset through RNA analysis during 18 to 22 weeks of gestation.